February 16, 2012

More Best Than Worst of Times for Area Biotech Sector

In the 12 years of Ingram's Industry Outlook assembly series, Polsinelli Shughart's Kevin Sweeney did something that no previous chair had thought to do: begin his presentation with a recitation from Charles Dickens.

"It was the best of times, it was the worst of times," said Sweeney, who proceeded to read the rest of the entirely apt opening paragraph of The Tale of Two Cities. This excerpt summarized Sweeney's feelings on the state of the biotech industry in this region.

Recently, some of the thought leaders in the biotech community gathered at Polsinelli Shughart for a substantive discussion of biotech today. Leading the discussion included Polsinelli Shughart's Life Sciences Chair Kevin Sweeney and Science and Technology Chair Patrick Woolley.

To read a transcript of the event, which is featured in Ingram's, click on the link below.

To read, click here

About Kevin Sweeney

Kevin Sweeney is Chair of Polsinelli Shughart's multidisciplinary Life Sciences practice group and a senior member of its Corporate Finance group. He has more than 25 years experience in handling mergers and acquisitions, public and private securities offerings, venture capital financing, technology transfer, and other complex financial and strategic transactions for clients in a wide variety of industries, with a special emphasis in serving as a strategic advisor to the top management of life science companies of all types and stages of development. He is a strategic partner to many emerging and growth companies, assisting in the development and implementation of their business, financial and legal goals.

About Patrick Woolley

As practice group chair, Patrick C. Woolley has helped to grow the firm's Science and Technology practice from its inception to over 35 lawyers and scientists. In his practice, Mr. Woolley has worked in a variety of areas including patents, trademarks, copyright, licensing, litigation, trade secret litigation and business advice and guidance. His practice has included both domestic and foreign issues, with Mr. Woolley having done significant work in Australia, Canada, Europe and Japan. Mr. Woolley has worked with startup companies, federal agencies, individual inventors and university/research institutions. In particular, Mr. Woolley has managed the entire intellectual property portfolio for a Fortune 500 company, as well as for a major research institution. His duties have included patent and trademark preparation and prosecution, patentability secrets, freedom to operate opinions, licensing and asset management, product design around and development, business guidance for new products, and development of a portfolio to promote VC investment or sale of assets.